FDA Approves Milestone Oral Therapy for Adults With Thalassemia AnemiaByAislinn Antrim, Managing EditorDecember 24th 2025
FDA Approves 1-Minute SC Mosunetuzumab for R/R Follicular LymphomaByLaura Joszt, MADecember 24th 2025
Expert: Streamlining Infusion Workflows Without Compromising Patient ExperienceByKennedy Ferruggia, Assistant Editor,Prateek Bhatia, BPharm, PhDDecember 23rd 2025
Reading Between the Codes: How Seemingly Unrelated Conditions May Signal Earlier Multiple MyelomaByFaith Davies, MD,Aislinn Antrim, Managing EditorDecember 22nd 2025